See veebileht kasutab küpsiseid kasutaja sessiooni andmete hoidmiseks. Veebilehe kasutamisega nõustute ETISe kasutustingimustega. Loe rohkem
Olen nõus
"Muu" projekt VFP558
VFP558 "CHROMED: Clinical evaluation of a new multi-parametric monitoring system for patients affected by COPD with CHF or sleep disorders comorbidities (1.10.2012−31.12.2015)", Ruth Sepper, Tallinna Tehnikaülikool, TTÜ Tehnomeedikum, Kliinilise meditsiini instituut .
VFP558
CHROMED: Clinical evaluation of a new multi-parametric monitoring system for patients affected by COPD with CHF or sleep disorders comorbidities
CHROMED: Clinical evaluation of a new multi-parametric monitoring system for patients affected by COPD with CHF or sleep disorders comorbidities
1.10.2012
31.12.2015
Teadus- ja arendusprojekt
Muu
EU HEALTH.2012.2.2.2-2 HEALTH
ETIS klassifikaatorAlamvaldkondCERCS klassifikaatorFrascati Manual’i klassifikaatorProtsent
3. Terviseuuringud3.7. Kliiniline meditsiinB540 Hingamissüsteemi haigused 3.2. Kliiniline meditsiin (anestesioloogia, pediaatria, sünnitusabi ja günekoloogia, sisehaigused, kirurgia, stomatoloogia, neuroloogia, psühhiaatria, radioloogia, terapeutika, otorinolarüngoloogia, oftalmoloogia)60,0
AsutusRiikTüüp
FP7-HEALTH-2012-INNOVATION-1
PerioodSumma
01.10.2012−31.12.2015275 795,00 EUR
275 795,00 EUR

The objective of CHROMED project is to evaluate the impact of adopting a health and lifestyle status management system to support elderly patients with a combination of chronic diseases involving respiratory and cardiovascular systems. A large scale clinical trial will be implemented to develop and evaluate clinical protocols and organizational models based on the new technologies in order to improve both quality of life and healthcare costs associated with these patients. The CHROMED idea arises from a previously successful research experience in patient monitoring at home. The CHROMED project focuses its investigation on the applicability of an integrated solution for a pathological condition which: a) is very prevalent in ageing patients and b) severely impairs quality of life: COPD with other typical comorbidities such as congestive heart failure and sleep disordered breathing. An international multi-centric randomized control trial will be implemented in five European regions: United Kingdom, Sweden, Estonia, Spain and Slovenia, representing different social and organizational contexts in Europe. In each country, the participating care organizations have existing practices and procedures for age-related disease management. In CHROMED a specific ICT platform in combination with a set of both well established and innovative devices will be used to collect and process useful clinical data at the patient’s home. In particular, for each patient a set of devices will be defined considering the existing co-morbidities
KirjeldusProtsent
Katse- ja arendustöö50,0
Rakendusuuring50,0